Plus, news about Retension Pharmaceuticals:
Vandria tops up Series A with another $10M: The Swiss biotech increased its round total to …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian here
Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us
Share this article As per the agreement, Astellas holds the right to include up to two more programmes in the partnership. Credit: JHVEPhoto / Shutterstock.com.